Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461732 · ClinicalTrials.gov registry record · NA
Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02461732 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants.
The verdict
NCT02461732, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether a novel integrated cognitive-behavioral treatment for posttraumatic stress disorder (PTSD) and substance dependence (i.e., Treatment for Integrated Posttraumatic Stress and Substance use; TIPSS) is more effective than cognitive-behavioral treatment for substance dependence alone with regard to PTSD symptoms and substance use quantity and frequency.
Interventions
- BEHAVIORAL Treatment for Integrated Posttraumatic Stress and Substance Use (TIPSS)
- BEHAVIORAL Cognitive-Behavioral Therapy for Substance Dependence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461732
The ClinicalTrials.gov registry entry for NCT02461732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment for Integrated Posttraumatic Stress and Substance Use (TIPSS) is the first listed.
NCT02461732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02461732 about?
NCT02461732 is a clinical study titled "Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence". The purpose of the study is to determine whether a novel integrated cognitive-behavioral treatment for posttraumatic stress disorder (PTSD) and substance dependence (i.e., Treatment for Integrated Posttraumatic Stress and Substance use; TIPSS) is more effective than cognitive-behavioral treatment fo...
What is the current status of trial NCT02461732?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02461732?
The interventions under investigation include: Treatment for Integrated Posttraumatic Stress and Substance Use (TIPSS) (BEHAVIORAL), Cognitive-Behavioral Therapy for Substance Dependence (BEHAVIORAL).
Who is sponsoring clinical trial NCT02461732?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.